C-Mer Eye Care Holdings Completes IPO and Listing on the Hong Kong Stock Exchange

On January 15, 2018, C-Mer Eye Care Holdings Limited, a leading ophthalmic service provider in Hong Kong, completed its IPO and has been listed on the Main Board of the Stock Exchange of Hong Kong. The offering included an offering of 197,000,000 shares, subject to the over-allotment option, with gross proceeds of approximately HK$571 million. The publicly offered shares were more than 1,500 times oversubscribed. Wilson Sonsini Goodrich & Rosati advised China Merchants Securities (HK) Co., the sole sponsor, global coordinator, and bookrunner, in connection with the offering and listing.

C-Mer's pre-IPO investors included companies ultimately owned or controlled by Sun Hung Kai Properties Limited or trusts for the benefit of certain family members of the Kwok family, as well as LKF Capital Partners, which is wholly owned by Dr. Allan Zeman. The issuer's cornerstone investors included an investment company wholly owned by Mr. Huateng Ma, an investment company wholly owned by Mr. Yung Chiu, and a third investment company that is 100 percent controlled by the trustee of a discretionary trust set up by Mr. Michael Lee Yuen Ying.

The WSGR team that advised China Merchants Securities was led by partner KJ Tan and included associates Winfield Lau and Yuki Chan.

For more information, please see C-Mer Eye Care's announcement.